Loading Page..

Knowledge Content Library

99
Generating Actionable Strategic Alternatives
Presented by Rick Bayney (BristolMyersSquibb) at 2001 DAAG Conference in Houston. Discussion of developing strategies as a key part of portfolio analysis.

100
How to Do Absolutely Everything Wrong and Then Fix It
Presented at 2001 DAAG Conference in Houston. Discussion of the evolution of Decision Analysis methods in the 1990s in an under-performing Exploration group in an oil company.

101
Implementation of Decision Analysis at Novartis
Presented by (Novartis) at 2001 DAAG Conference in Houston. Discussion of the the issues at Novartis during implementation and adoption of Decision Analysis.

102
Implementation of Decision Analysis at Texaco
Presented by Dewey McLemore (Texaco) at 2001 DAAG Conference in Houston. Discussion of the the issues at Texaco during implementation and adoption of Decision Analysis.

103
Incremental Value Assessment: A DA Based Approach
Presented by (Bell Canada) at 2001 DAAG Conference in Houston. Overview of Bell Canada's Incremental Value Analysis (IVA) Process to do rapid assessments.

104
Integrating Decision Analysis into Other Business Processes
Presented by Bruce Collet (Petrous) at 2001 DAAG Conference in Houston. Discussion of strategy development and execution through integration of decision analysis with other business processes.

105
Is Price an Uncertainty or a Decision
Presented by (Eastman Kodak) at 2001 DAAG Conference in Houston. Discussion of situations where one may want to model price as an uncertainty versus a decision, including consideration of price-elasticity curves.

106
Misapplications of Decision Analysis
Presented by Hugh Taylor (DuPont) at 2001 DAAG Conference in Houston. Discusses examples of misapplications of DA, including improper framing.

107
Reliability and D&RA
Presented by (Conoco) at 2001 DAAG Conference in Houston. Discussion of Conoco's applications of Decision Analysis to reliability modeling problems including integration with other work processes.

108
The Integration of D&RA and Project Development/Management
Presented by (Conoco) at 2001 DAAG Conference in Houston. Discussion of Conoco's D&RA process and its integration with other business processes.

109
Value of Information Misapplied
Presented by Phil Kerig and Brent Weber (Conoco) at 2001 DAAG Conference in Houston. Lessons learned from application of Value of Information - top five VOI pitfalls.

78
Useful Scenarios in 8 Hours or Less
Presented by Garrett Brauer (Eastman Kodak) at 2000 DAAG Conference in Calgary. Discussion of how to use scenario analysis as a tool for strategy development.

79
Update on the Value of DA
Presented by Bob Clemen (Duke University) at 2000 DAAG Conference in Calgary. An update on the value of DA based on survey responses and experience from Kodak.

80
Decision Analysis to Evaluate Possible Early Allocation of Phase 3 Resources
Presented by C. Hallford (Eli Lilly) at 2000 DAAG Conference in Calgary. An analysis of the benefits and risks of accelerating the timing of allocating Phase 3 resources.

81
How Options Thinking Can Improve Decisions With No Calculation or Jargon
Presented by Jerry Lieberman (General Motors) at 2000 DAAG Conference in Calgary. Discussion of how thinking in options terms can lead to better decisions, without applying formal options theory.

82
Technology Choice When Delay is Costly
Presented by Mark Cronshaw (MediaOne) at 2000 DAAG Conference in Calgary. Analysis of timing of investing in technology, incorporating options type analysis with decision trees.

83
Real Options in Practice: Two Examples from the Energy Sector
Presented by Sue Lisowski (Texaco) at 2000 DAAG Conference in Calgary. Examples of real options applied to a new technology decision and to an offshore development decision.

84
Proof of Concept in Drug Development
Presented by Stuart Harris (GlaxoSmithKline) at 2000 DAAG Conference in Calgary. Application of value of imperfect information analysis to proof of concept in drug development.

85
Lessons about Options from a Pharmaceutical R&D Project
Presented by Tom Spradlin (Eli Lilly) at 2000 DAAG Conference in Calgary. Discussion of options applications to the phased decisions inherent in the drug development cycle.

86
Keep the Bath Water Too: Value Beyond the Strategy Product
Presented by Sabrina Watkins, Paul McNutt, Laine Summers (Conoco) at 2000 DAAG Conference in Calgary. Discussion of strategy development and value in E&P in Conoco.

Stay connected